Date of Decision: JUNE 4, 2019
Service Center: Nebraska Service Center
Form Type: Form I-140
Case Type: EB1 Extraordinary Ability
Petitioner Information
Profession: Senior Director in Project Management
Field: Pharmaceutical
Nationality: Not specified
Summary of Decision
Initial Decision: Denied
Appeal Outcome: Sustained
Evidentiary Criteria Analysis
Criteria Met:
Judging: The petitioner has reviewed manuscripts for “Nanomedicine: Nanotechnology, Biology, and Medicine.”
Scholarly Articles: Published articles in journals including Enzyme Engineering, the Journal of Chromatography, and Biochemistry and Analytical Biochemistry.
High Salary: Salaries above average as indicated by salary surveys from the American Association of Pharmaceutical Scientists.
Criteria Not Met:
Not applicable as the appeal was sustained with the criteria met being sufficient.
Key Points from the Decision
Awards and Prizes Won:
Not applicable as no specific awards were mentioned in the decision.
Published Materials About the Petitioner:
The petitioner has published extensively in recognized journals which contributes to his claim of extraordinary ability.
Original Contributions of Major Significance:
Significant contributions to the pharmaceutical industry including several patents and leadership in drug product development.
Participation as a Judge:
Actively participated in reviewing scientific manuscripts and abstracts, reinforcing his expertise and standing in the field.
Membership in Associations:
Member of a scientific advisory council, reflecting recognition by peers and contributions to pharmaceutical sciences.
Authorship of scholarly articles:
Authored several peer-reviewed articles in highly regarded scientific journals, contributing to his field’s body of knowledge.
Leading or critical role performed:
Led significant projects in pharmaceutical development, demonstrating leadership and impact on the industry.
Supporting Documentation
Documentation Provided:
- Salary surveys and employment documentation supporting high salary claims.
- Published articles and evidence of peer review activities.
- Letters from industry leaders acknowledging the petitioner’s contributions and leadership in the field.
Conclusion
Final Determination: The appeal is sustained as the petitioner has demonstrated extraordinary ability through sustained national and international acclaim recognized extensively in his field.
Reasoning:
The petitioner meets the criteria set by regulatory standards, proving his top-tier status in pharmaceuticals.
Next Steps:
The petitioner should continue to maintain and document his contributions and achievements in the field to support future applications or renewals.
